- Report
- October 2024
- 193 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- July 2024
- 110 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- January 2025
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- June 2023
- 236 Pages
Global
From €4699EUR$4,950USD£3,964GBP
The ATP Assay market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to measure the amount of adenosine triphosphate (ATP) present in a sample, which is an indicator of microbial contamination. ATP assays are used in a variety of industries, including food and beverage, pharmaceutical, and medical device manufacturing. They are also used in clinical laboratories to detect and monitor microbial contamination in patient samples.
ATP assays are becoming increasingly popular due to their accuracy, speed, and cost-effectiveness. They are also easy to use and require minimal sample preparation. This makes them ideal for use in a variety of settings, including clinical laboratories, food and beverage production facilities, and medical device manufacturing plants.
Some of the major companies in the ATP Assay market include 3M, Bio-Rad, Merck, Roche, and Thermo Fisher Scientific. These companies offer a wide range of products, including reagents, instruments, and software. They also provide technical support and training to ensure that their customers are able to use their products effectively. Show Less Read more